Home Our Children Donate Videos Contact Us
Symptoms Treatment & Diagnosis Genetic Counseling Scientific Research Mission and History President's Message Board of Directors Medical Advisory Board View Newsletter Sign Up for Newsletter

Videos


Mucolipidosis Type IV:
A Devastating Genetic Disease

Mucolipidosis Type IV (ML4), was first identified in 1974 as a genetic disease. Children with ML4 begin to exhibit developmental delay during the first year of life. Many parents seek opthomalogic evaluations for pseudo-strabismus and medical intervention for delayed motor milestones. Children with ML4 typically reach a maximum developmental age of 18 months in language and motor function, although their receptive abilities are more advanced.
Read more


 

ML4: The Name

ML4: The Scientific Diagnosis

ML4: The Gene Discovery

ML4: The Eye Sight


 

Donate to Jodi Gottlieb's Bat Mitzvah Project.

Donate Now
Do for ML4
Jewish American Hero
Randy Gold, ML4 Foundation Vice President, was named the 2011 Jewish Community Hero sponsored by the Jewish Federations® of North America for his efforts around promoting awareness of the 19 known preventable Jewish Genetic Diseases.
Jewish Genetic Disease Consortium National Organization for Rare Disorders Atlanta Jewish Gene Screen